Snake venoms: Attractive antimicrobial proteinaceous compounds for therapeutic purposes

Cellular and Molecular Life Sciences

Volumn 70, Issue 24, 2013, Pages 4645-4658

  De Oliveira Junior, Nelson Gomes ^a,b   E Silva Cardoso, Marlon Henrique ^a   Franco, Octavio Luiz ^a  

^a UNIVERSIDADE CATÓLICA DE BRASÍLIA   (Brazil)

^b UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

Antibiotics; Antimicrobials; Proteinaceous compounds; Snake venom

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING); ANTIINFECTIVE AGENT; CATHELICIDIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE BF 30; CROTAMINE; LEVO AMINE OXIDASE; METALLOPROTEINASE; MSI 367 PEPTIDE; MSI 594 PEPTIDE; NAWAPRIN; OMWAPRIN; PARDAXIN; PEP5B PEPTIDE; PEPBJ PEPTIDE; PHOSPHOLIPASE A2; POLYPEPTIDE ANTIBIOTIC AGENT; PROMUTOXIN; SNAKE VENOM; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; BACTERICIDAL ACTIVITY; CARBOXY TERMINAL SEQUENCE; DRUG BINDING; DRUG EFFICACY; DRUG SCREENING; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME STABILITY; HETEROLOGOUS EXPRESSION; HYDROPHOBICITY; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; PROTEIN CONFORMATION; PROTEIN DOMAIN; PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; PROTEIN SYNTHESIS; REVIEW; SEQUENCE ANALYSIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL INFECTIONS; HUMANS; L-AMINO ACID OXIDASE; METALLOPROTEASES; PHOSPHOLIPASES A2; PROTEIN CONFORMATION; SNAKE VENOMS;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 84889883966     PISSN: 1420682X     EISSN: 14209071     Source Type: Journal    
DOI: 10.1007/s00018-013-1345-x     Document Type: Review

References (98)

1. Vargas LJ, Londono M, Quintana JC, Rua C, Segura C, Lomonte B, Nunez V (2012) An acidic phospholipase A(2) with antibacterial activity from Porthidium nasutum snake venom. Comp Biochem Physiol B Biochem Mol Biol 161(4):341-347
2. Tashima AK, Zelanis A, Kitano ES, Ianzer D, Melo RL, Rioli V, Sant'anna SS, Schenberg AC, Camargo AC, Serrano SM (2012) Peptidomics of three Bothrops snake venoms: insights into the molecular diversification of proteomes and peptidomes. Mol Cell Proteomics 11:1245-1262
3. Warshawsky H, Haddad A, Goncalves RP, Valeri V, De Lucca FL (1973) Fine structure of the venom gland epithelium of the South American rattlesnake and radioautographic studies of protein formation by the secretory cells. Am J Anat 138(1):79-119
4. Calvete JJ, Sanz L, Angulo Y, Lomonte B, Gutierrez JM (2009) Venoms, venomics, antivenomics. FEBS Lett 583(11):1736-1743
5. Six DA, Dennis EA (2000) The expanding superfamily of phospholipase A(2) enzymes: classification and characterization. Biochim Biophys Acta 1488(1-2):1-19
6. Dennis EA (1994) Diversity of group types, regulation, and function of phospholipase A2. J Biol Chem 269(18):13057-13060
7. Wei JF, Li T, Wei XL, Sun QY, Yang FM, Chen QY, Wang WY, Xiong YL, He SH (2006) Purification, characterization and cytokine release function of a novel Arg-49 phospholipase A(2) from the venom of Protobothrops mucrosquamatus. Biochimie 88(10):1331-1342
8. Huancahuire-Vega S, Ponce-Soto LA, Martins-de-Souza D, Marangoni S (2011) Biochemical and pharmacological characterization of PhTX-I a new myotoxic phospholipase A2 isolated from Porthidium hyoprora snake venom. Comp Biochem Physiol Toxicol Pharmacol 154(2):108-119. doi: 10.1016/j.cbpc.2011.03.013
9. Lu QM, Jin Y, Wei JF, Li DS, Zhu SW, Wang WY, Xiong YL (2002) Characterization and cloning of a novel phospholipase A(2) from the venom of Trimeresurus jerdonii snake. Toxicon 40(9):1313-1319
10. Kini RM (2005) Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms. Toxicon 45(8):1147-1161. doi: 10.1016/j.toxicon.2005.02.018
11. Lu QM, Jin Y, Wei JF, Wang WY, Xiong YL (2002) Biochemical and biological properties of Trimeresurus jerdonii venom and characterization of a platelet aggregation-inhibiting acidic phospholipase A2. J Nat Toxins 11(1):25-33
12. Tsai IH, Lu PJ, Wang YM, Ho CL, Liaw LL (1995) Molecular cloning and characterization of a neurotoxic phospholipase A2 from the venom of Taiwan habu (Trimeresurus mucrosquamatus). Biochem J 311(Pt 3):895-900
13. Ketelhut DFJ, Homem de Mello M, Veronese ELG, Esmeraldino LE, Murakami MT, Arni RK, Giglio JR, Cintra ACO, Sampaio SV (2003) Isolation, characterization and biological activity of acidic phospholipase A2 isoforms from Bothrops jararacussu snake venom. Biochimie 85(10):983-991. doi: 10.1016/j.biochi.2003.09.011
14. Hoskin DW, Ramamoorthy A (2008) Studies on anticancer activities of antimicrobial peptides. Biochim Biophys Acta 1778(2):357-375. doi: 10.1016/j.bbamem.2007.11.008
15. Xu C, Ma D, Yu H, Li Z, Liang J, Lin G, Zhang Y, Lai R (2007) A bactericidal homodimeric phospholipases A2 from Bungarus fasciatus venom. Peptides 28(5):969-973. doi: 10.1016/j.peptides.2007.02.008
16. Du XY, Clemetson KJ (2002) Snake venom l-amino acid oxidases. Toxicon 40(6):659-665
17. Santamaria C, Larios S, Quiros S, Pizarro-Cerda J, Gorvel JP, Lomonte B, Moreno E (2005) Bactericidal and antiendotoxic properties of short cationic peptides derived from a snake venom Lys49 phospholipase A2. Antimicrob Agents Chemother 49(4):1340-1345
18. Lee ML, Tan NH, Fung SY, Sekaran SD (2011) Antibacterial action of a heat-stable form of l-amino acid oxidase isolated from king cobra (Ophiophagus hannah) venom. Comp Biochem Physiol Toxicol Pharmacol 153(2):237-242. doi: 10.1016/j.cbpc.2010.11.001
19. Gutierrez JM, Rucavado A, Escalante T, Diaz C (2005) Hemorrhage induced by snake venom metalloproteinases: biochemical and biophysical mechanisms involved in microvessel damage. Toxicon 45(8):997-1011. doi: 10.1016/j.toxicon.2005.02.029
20. White J (2005) Snake venoms and coagulopathy. Toxicon 45(8):951-967. doi: 10.1016/j.toxicon.2005.02.030
21. Fox JW, Serrano SM (2005) Structural considerations of the snake venom metalloproteinases, key members of the M12 reprolysin family of metalloproteinases. Toxicon 45(8):969-985
22. Fox JW, Serrano SM (2008) Insights into and speculations about snake venom metalloproteinase (SVMP) synthesis, folding and disulfide bond formation and their contribution to venom complexity. FEBS J 275(12):3016-3030. doi: 10.1111/j.1742-4658.2008.06466.x
23. Jia LG, Shimokawa K, Bjarnason JB, Fox JW (1996) Snake venom metalloproteinases: structure, function and relationship to the ADAMs family of proteins. Toxicon 34(11-12):1269-1276
24. Markland FS Jr, Swenson S (2012) Snake venom metalloproteinases. Toxicon. doi: 10.1016/j.toxicon.2012.09.004
25. Akao PK, Tonoli CC, Navarro MS, Cintra AC, Neto JR, Arni RK, Murakami MT (2010) Structural studies of BmooMPalpha-I, a non-hemorrhagic metalloproteinase from Bothrops moojeni venom. Toxicon 55(2-3):361-368. doi: 10.1016/j.toxicon. 2009.08.013
26. Samy RP, Gopalakrishnakone P, Chow VT, Ho B (2008) Viper metalloproteinase (Agkistrodon halys pallas) with antimicrobial activity against multi-drug resistant human pathogens. J Cell Physiol 216(1):54-68
27. Sun Y, Nonobe E, Kobayashi Y, Kuraishi T, Aoki F, Yamamoto K, Sakai S (2002) Characterization and expression of l-amino acid oxidase of mouse milk. J Biol Chem 277(21):19080-19086. doi: 10.1074/jbc.M200936200
28. Kasai K, Ishikawa T, Komata T, Fukuchi K, Chiba M, Nozaka H, Nakamura T, Sato T, Miura T (2010) Novel l-amino acid oxidase with antibacterial activity against methicillin-resistant Staphylococcus aureus isolated from epidermal mucus of the flounder Platichthys stellatus. FEBS J 277(2):453-465. doi: 10.1111/j.1742-4658.2009.07497.x
29. Okubo BM, Silva ON, Migliolo L, Gomes DG, Porto WF, Batista CL, Ramos CS, Holanda HH, Dias SC, Franco OL, Moreno SE (2012) Evaluation of an antimicrobial l-amino acid oxidase and peptide derivatives from Bothropoides mattogrosensis pitviper venom. PLoS One 7(3):e33639
30. Georgieva D, Murakami M, Perband M, Arni R, Betzel C (2011) The structure of a native l-amino acid oxidase, the major component of the Vipera ammodytes venomic, reveals dynamic active site and quaternary structure stabilization by divalent ions. Mol BioSyst 7(2):379-384. doi: 10.1039/c0mb00101e
31. Nair DG, Fry BG, Alewood P, Kumar PP, Kini RM (2007) Antimicrobial activity of omwaprin, a new member of the waprin family of snake venom proteins. Biochem J 402(1):93-104
32. Toyama MH, Toyama Dde O, Passero LF, Laurenti MD, Corbett CE, Tomokane TY, Fonseca FV, Antunes E, Joazeiro PP, Beriam LO, Martins MA, Monteiro HS, Fonteles MC (2006) Isolation of a new l-amino acid oxidase from Crotalus durissus cascavella venom. Toxicon 47(1):47-57. doi: 10.1016/j.toxicon.2005.09. 008
33. Zhang H, Yang Q, Sun M, Teng M, Niu L (2004) Hydrogen peroxide produced by two amino acid oxidases mediates antibacterial actions. J Microbiol 42(4):336-339
34. Pereira HA (2006) Novel therapies based on cationic antimicrobial peptides. Curr Pharm Biotechnol 7(4):229-234
35. Splith K, Neundorf I (2011) Antimicrobial peptides with cell-penetrating peptide properties and vice versa. Eur Biophys J 40(4):387-397
36. Wang Y, Hong J, Liu X, Yang H, Liu R, Wu J, Wang A, Lin D, Lai R (2008) Snake cathelicidin from Bungarus fasciatus is a potent peptide antibiotics. PLoS One 3(9):e3217. doi: 10.1371/journal.pone.0003217
37. Epand RM, Vogel HJ (1999) Diversity of antimicrobial peptides and their mechanisms of action. Biochim Biophys Acta 1462(1-2):11-28
38. Ramamoorthy A, Lee DK, Narasimhaswamy T, Nanga RP (2010) Cholesterol reduces pardaxin's dynamics-a barrel-stave mechanism of membrane disruption investigated by solid-state NMR. Biochim Biophys Acta 1798(2):223-227. doi: 10.1016/j.bbamem.2009.08.012
39. Bhunia A, Domadia PN, Torres J, Hallock KJ, Ramamoorthy A, Bhattacharjya S (2010) NMR structure of pardaxin, a pore-forming antimicrobial peptide, in lipopolysaccharide micelles: mechanism of outer membrane permeabilization. J Biol Chem 285(6):3883-3895. doi: 10.1074/jbc.M109.065672
40. Kandasamy SK, Lee DK, Nanga RP, Xu J, Santos JS, Larson RG, Ramamoorthy A (2009) Solid-state NMR and molecular dynamics simulations reveal the oligomeric ion-channels of TM2-GABA(A) stabilized by intermolecular hydrogen bonding. Biochim Biophys Acta 1788(3):686-695. doi: 10.1016/j.bbamem.2008.11.009
41. Maloy WL, Kari UP (1995) Structure-activity studies on magainins and other host defense peptides. Biopolymers 37(2):105-122. doi: 10.1002/bip.360370206
42. Bhattacharjya S, Ramamoorthy A (2009) Multifunctional host defense peptides: functional and mechanistic insights from NMR structures of potent antimicrobial peptides. FEBS J 276(22):6465-6473. doi: 10.1111/j.1742-4658.2009. 07357.x
43. Ramamoorthy A (2009) Beyond NMR spectra of antimicrobial peptides: dynamical images at atomic resolution and functional insights. Solid State Nucl Magn Reson 35(4):201-207. doi: 10.1016/j.ssnmr.2009.03.003
44. Shai Y (1999) Mechanism of the binding, insertion and destabilization of phospholipid bilayer membranes by alpha-helical antimicrobial and cell non-selective membrane-lytic peptides. Biochim Biophys Acta 1462(1-2):55-70
45. Gottler LM, Ramamoorthy A (2009) Structure, membrane orientation, mechanism, and function of pexiganan-a highly potent antimicrobial peptide designed from magainin. Biochem Biophys Acta 1788(8):1680-1686. doi: 10.1016/j.bbamem.2008.10.009
46. Epand RF, Maloy WL, Ramamoorthy A, Epand RM (2010) Probing the "charge cluster mechanism" in amphipathic helical cationic antimicrobial peptides. Biochemistry 49(19):4076-4084. doi: 10.1021/bi100378m
47. Epand RF, Maloy L, Ramamoorthy A, Epand RM (2010) Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline states in the presence of phosphatidylglycerol: lipid clustering in anionic membranes. Biophys J 98(11):2564-2573. doi: 10.1016/j.bpj.2010.03.002
48. Bhunia A, Ramamoorthy A, Bhattacharjya S (2009) Helical hairpin structure of a potent antimicrobial peptide MSI-594 in lipopolysaccharide micelles by NMR spectroscopy. Chemistry 15(9):2036-2040. doi: 10.1002/chem.200802635
49. Delcour AH (2009) Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta 1794(5):808-816. doi: 10.1016/j.bbapap.2008.11.005
50. Abu-Youssef MA, Soliman SM, Langer V, Gohar YM, Hasanen AA, Makhyoun MA, Zaky AH, Ohrstrom LR (2010) Synthesis, crystal structure, quantum chemical calculations, DNA interactions, and antimicrobial activity of [Ag(2-amino-3-methylpyridine)(2)]NO(3) and [Ag(pyridine-2-carboxaldoxime)NO(3)]. Inorg Chem 49(21):9788-9797. doi: 10.1021/ic100581k
51. Dathe M, Wieprecht T (1999) Structural features of helical antimicrobial peptides: their potential to modulate activity on model membranes and biological cells. Biochim Biophys Acta 1462(1-2):71-87
52. Ding L, Yang L, Weiss TM, Waring AJ, Lehrer RI, Huang HW (2003) Interaction of antimicrobial peptides with lipopolysaccharides. Biochemistry 42(42):12251-12259. doi: 10.1021/bi035130+
53. Bhattacharjya S (2010) De novo designed lipopolysaccharide binding peptides: structure based development of antiendotoxic and antimicrobial drugs. Curr Med Chem 17(27):3080-3093
54. Raetz CR, Whitfield C (2002) Lipopolysaccharide endotoxins. Annu Rev Biochem 71:635-700. doi: 10.1146/annurev.biochem.71.110601.135414
55. Domadia PN, Bhunia A, Ramamoorthy A, Bhattacharjya S (2010) Structure, interactions, and antibacterial activities of MSI-594 derived mutant peptide MSI-594F5A in lipopolysaccharide micelles: role of the helical hairpin conformation in outer-membrane permeabilization. J Am Chem Soc 132(51):18417-18428. doi: 10.1021/ja1083255
56. Brender JR, McHenry AJ, Ramamoorthy A (2012) Does cholesterol play a role in the bacterial selectivity of antimicrobial peptides? Front Immunol 3:195. doi: 10.3389/fimmu.2012.00195
57. Hancock RE (1984) Alterations in outer membrane permeability. Annu Rev Microbiol 38:237-264. doi: 10.1146/annurev.mi.38.100184.001321
58. Bhunia A, Domadia PN, Bhattacharjya S (2007) Structural and thermodynamic analyses of the interaction between melittin and lipopolysaccharide. Biochim Biophys Acta 1768(12):3282-3291. doi: 10.1016/j.bbamem.2007.07.017
59. Matsuzaki K, Sugishita K, Harada M, Fujii N, Miyajima K (1997) Interactions of an antimicrobial peptide, magainin 2, with outer and inner membranes of Gram-negative bacteria. Biochim Biophys Acta 1327(1):119-130
60. Lazarovici P, Primor N, Loew LM (1986) Purification and pore-forming activity of two hydrophobic polypeptides from the secretion of the Red Sea Moses sole (Pardachirus marmoratus). J Biol Chem 261(35):16704-16713
61. Epand RF, Ramamoorthy A, Epand RM (2006) Membrane lipid composition and the interaction of pardaxin: the role of cholesterol. Protein Pept Lett 13(1):1-5
62. Hallock KJ, Lee DK, Omnaas J, Mosberg HI, Ramamoorthy A (2002) Membrane composition determines pardaxin's mechanism of lipid bilayer disruption. Biophys J 83(2):1004-1013. doi: 10.1016/S0006-3495(02)75226-0
63. Porcelli F, Buck B, Lee DK, Hallock KJ, Ramamoorthy A, Veglia G (2004) Structure and orientation of pardaxin determined by NMR experiments in model membranes. J Biol Chem 279(44):45815-45823. doi: 10.1074/jbc.M405454200
64. Zanetti M (2004) Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 75(1):39-48
65. Durr UH, Sudheendra US, Ramamoorthy A (2006) LL-37, the only human member of the cathelicidin family of antimicrobial peptides. Biochim Biophys Acta 1758(9):1408-1425
66. Zhou H, Dou J, Wang J, Chen L, Wang H, Zhou W, Li Y, Zhou C (2011) The antibacterial activity of BF-30 in vitro and in infected burned rats is through interference with cytoplasmic membrane integrity. Peptides 32(6):1131-1138. doi: 10.1016/j.peptides.2011.04.002
67. Oguiura N, Boni-Mitake M, Affonso R, Zhang G (2011) In vitro antibacterial and hemolytic activities of crotamine, a small basic myotoxin from rattlesnake Crotalus durissus. J Antibiot 64(4):327-331. doi: 10.1038/ja.2011.10
68. Boni-Mitake M, Costa H, Spencer PJ, Vassilieff VS, Rogero JR (2001) Effects of (60)Co gamma radiation on crotamine. Brazilian journal of medical and biological research. Rev Bras Pesqui Med Biol 34 (12):1531-1538
69. Gomes VM, Carvalho AO, Da Cunha M, Keller MN, Bloch C Jr, Deolindo P, Alves EW (2005) Purification and characterization of a novel peptide with antifungal activity from Bothrops jararaca venom. Toxicon 45(7):817-827
70. Torres AM, Wong HY, Desai M, Moochhala S, Kuchel PW, Kini RM (2003) Identification of a novel family of proteins in snake venoms. Purification and structural characterization of nawaprin from Naja nigricollis snake venom. J Biol Chem 278(41):40097-40104
71. Thompson RC, Ohlsson K (1986) Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc Natl Acad Sci USA 83(18):6692-6696
72. Wiedow O, Schroder JM, Gregory H, Young JA, Christophers E (1990) Elafin: an elastase-specific inhibitor of human skin. Purification, characterization, and complete amino acid sequence. J Biol Chem 265(25):14791-14795
73. Larsen M, Ressler SJ, Lu B, Gerdes MJ, McBride L, Dang TD, Rowley DR (1998) Molecular cloning and expression of ps20 growth inhibitor. A novel WAP-type "four-disulfide core" domain protein expressed in smooth muscle. J Biol Chem 273(8):4574-4584
74. Hagiwara K, Kikuchi T, Endo Y, Huqun, Usui K, Takahashi M, Shibata N, Kusakabe T, Xin H, Hoshi S, Miki M, Inooka N, Tokue Y, Nukiwa T (2003) Mouse SWAM1 and SWAM2 are antibacterial proteins composed of a single whey acidic protein motif. J Immunol 170 (4):1973-1979
75. Gordon YJ, Romanowski EG, McDermott AM (2005) A review of antimicrobial peptides and their therapeutic potential as anti-infective drugs. Curr Eye Res 30(7):505-515
76. Ntwasa M, Goto A, Kurata S (2012) Coleopteran antimicrobial peptides: prospects for clinical applications. Int J Microbiol 2012:101989
77. Silva ON, Mulder KC, Barbosa AE, Otero-Gonzalez AJ, Lopez-Abarrategui C, Rezende TM, Dias SC, Franco OL (2012) Exploring the pharmacological potential of promiscuous host-defense peptides: from natural screenings to biotechnological applications. Front Microbiol 2:232
78. Bienert A, Wiczling P, Grzeskowiak E, Cywinski JB, Kusza K (2012) Potential pitfalls of propofol target controlled infusion delivery related to its pharmacokinetics and pharmacodynamics. Pharmacol Rep 64(4):782-795
79. Mehvar R (2012) Confounding issues in estimation of patient-specific pharmacokinetic parameters and dosage individualization of aminoglycosides. Curr Clin Pharmacol 7:28-35
80. Misra A, Hickey AJ, Rossi C, Borchard G, Terada H, Makino K, Fourie PB, Colombo P (2011) Inhaled drug therapy for treatment of tuberculosis. Tuberculosis 91(1):71-81. doi: 10.1016/j.tube.2010.08.009
81. Mouton JW, Ambrose PG, Canton R, Drusano GL, Harbarth S, MacGowan A, Theuretzbacher U, Turnidge J (2011) Conserving antibiotics for the future: new ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective. Drug Resist Updat 14(2):107-117. doi: 10.1016/j.drup.2011.02.005
82. MacGregor RR, Graziani AL (1997) Oral administration of antibiotics: a rational alternative to the parenteral route. Clin Infect Dis 24(3):457-467
83. Pison U, Welte T, Giersig M, Groneberg DA (2006) Nanomedicine for respiratory diseases. Eur J Pharmacol 533(1-3):341-350
84. Zhou C, Qi X, Li P, Chen WN, Mouad L, Chang MW, Leong SS, Chan-Park MB (2010) High potency and broad-spectrum antimicrobial peptides synthesized via ring-opening polymerization of alpha-aminoacid-N-carboxyanhydrides. Biomacromolecules 11(1):60-67
85. Hancock RE, Sahl HG (2006) Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol 24(12):1551-1557
86. Tay DK, Rajagopalan G, Li X, Chen Y, Lua LH, Leong SS (2011) A new bioproduction route for a novel antimicrobial peptide. Biotechnol Bioeng 108(3):572-581
87. Rao XC, Li S, Hu JC, Jin XL, Hu XM, Huang JJ, Chen ZJ, Zhu JM, Hu FQ (2004) A novel carrier molecule for high-level expression of peptide antibiotics in Escherichia coli. Protein Expr Purif 36(1):11-18
88. Desai PN, Shrivastava N, Padh H (2010) Production of heterologous proteins in plants: strategies for optimal expression. Biotechnol Adv 28(4):427-435. doi: 10.1016/j.biotechadv.2010.01.005
89. Li Y, Chen Z (2008) RAPD: a database of recombinantly-produced antimicrobial peptides. FEMS Microbiol Lett 289(2):126-129. doi: 10.1111/j.1574-6968.2008.01357.x
90. Sorensen HP, Mortensen KK (2005) Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 115(2):113-128. doi: 10.1016/j.jbiotec.2004.08.004
91. Li Y (2011) Recombinant production of antimicrobial peptides in Escherichia coli: a review. Protein Expr Purif 80(2):260-267. doi: 10.1016/j.pep.2011.08.001
92. Parachin NS, Mulder KC, Viana AA, Dias SC, Franco OL (2012) Expression systems for heterologous production of antimicrobial peptides. Peptides. doi: 10.1016/j.peptides.2012.09.020
93. Cregg JM, Tolstorukov I, Kusari A, Sunga J, Madden K, Chappell T (2009) Expression in the yeast Pichia pastoris. Methods Enzymol 463:169-189. doi: 10.1016/S0076-6879(09)63013-5
94. Romanos MA, Scorer CA, Clare JJ (1992) Foreign gene expression in yeast: a review. Yeast 8(6):423-488. doi: 10.1002/yea.320080602
95. Werner T, Morris MB, Dastmalchi S, Church WB (2012) Structural modelling and dynamics of proteins for insights into drug interactions. Adv Drug Deliv Rev 64(4):323-343. doi: 10.1016/j.addr.2011.11.011
96. Thennarasu S, Huang R, Lee DK, Yang P, Maloy L, Chen Z, Ramamoorthy A (2010) Limiting an antimicrobial peptide to the lipid-water interface enhances its bacterial membrane selectivity: a case study of MSI-367. Biochemistry 49(50):10595-10605. doi: 10.1021/bi101394r
97. McHenry AJ, Sciacca MF, Brender JR, Ramamoorthy A (2012) Does cholesterol suppress the antimicrobial peptide induced disruption of lipid raft containing membranes? Biochim Biophys Acta 1818(12):3019-3024. doi: 10.1016/j.bbamem.2012. 07.021
98. Dhople V, Krukemeyer A, Ramamoorthy A (2006) The human beta-defensin-3, an antibacterial peptide with multiple biological functions. Biochim Biophys Acta 1758(9):1499-1512. doi: 10.1016/j.bbamem.2006.07.007